INOSITA PLUS TAB
Inosita Plus
Generic Name: Sitagliptin + Metformin
Therapeutic Segment: Anti-diabetic
Indication:
Diabetes Mellitus Type II when treatment with Sitagliptin and Metformin is in-appropriate
Available as: Tablets
Strength: 50/500 mg , 50/850 mg , 50/1000 mg
- Endorsed by AACE guideline, as monotherapy or combination therapy.
- Provides HbA1c reduction with better tolerability.
- Low risk of hypoglycemia and weight neutral therapy.
- Sitagliptin 50/1000 mg provides superior goal attainment on T2D.
- Strong Efficacy as an add on therapy.
